Mahana Therapeutics signs agreement with Consumer Health division of Bayer to commercialize digital therapeutics

Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.

from Breaking World Pharma News https://ift.tt/QnfEopm